CD38 and acute myeloid leukemia: Recently, de Leeuw et al. compared LSCs (CD34+ CD38−) versus HSCs, and LSCs versus leukemic progenitors (CD34+ CD38+), all from the same AML BM, identifying multiple differentially expressed miRNAs.